Drug Prices

Jul 16, 2018
The AHA today submitted comments on the Department of Health and Human Services’ blueprint to lower drug prices and out-of-pocket costs. The letter provides input on issues related to competition, transparency in drug pricing, national drug spending data, value-based payment arrangements, site-…
Jun 26, 2018
The Senate Finance Committee today held a hearing on strategies to reduce prescription drug costs and encourage innovation and competition in the market. Health and Human Services Secretary Alex Azar testified on the administration’s blueprint to lower drug prices, released in May. In a statement…
Jul 17, 2018
AHA statement before the Senate Committee on Health, Education, Labor and Pensions on Reducing Health Care Costs: Eliminating Excess Health Care Spending and Improving Quality and Value for Patients.”
Jul 16, 2018
AHA comments on the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Jul 12, 2018
The AHA appreciates the Medicare Payment Advisory Commission’s concerns about rising pharmaceutical costs and urged the Commission to continue to take action to achieve sustainable drug pricing. “Hospitals, and the clinicians who work in them, know firsthand the lifesaving potential of drug…
Jul 10, 2018
Statement of the American Hospital Association for the Energy and Commerce Subcommittee on Health of the U.S. House of Representatives for the July 11, 2018 hearing on “Opportunities to Improve the 340B Drug Pricing Program”
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, including more than 1,900 hospitals that participate in the 340B drug savings program, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other…
Jul 9, 2018
The 340B drug savings program must be reformed, Health and Human Services Secretary Alex Azar said today at a 340B conference in Washington, D.C. Azar spoke about the need for “greater transparency surrounding how these [340B] discounts are being used” and “reforms to reduce the gap between…
Jun 27, 2018
The Health, Education, Labor and Pensions Committee today held the first in a series of hearings on how to reduce health care costs, which will examine administrative costs and waste, how to improve transparency, private sector solutions and other issues. Witnesses at today’s hearing included…
Jun 26, 2018
AHA statement before the Senate Finance Committee on "Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market."
Jun 19, 2018
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions regarding “Effective Administration of the 340B Drug Pricing Program.”